Medical Device Regulations: Clinical Impact...Medical Devices 19/03/2018 4 Iterative development vs....
Transcript of Medical Device Regulations: Clinical Impact...Medical Devices 19/03/2018 4 Iterative development vs....
![Page 1: Medical Device Regulations: Clinical Impact...Medical Devices 19/03/2018 4 Iterative development vs. disruptive development 19/03/2018 5 Clinical Evaluation Post-Market data Clinical](https://reader030.fdocuments.net/reader030/viewer/2022040611/5ed4b83b0b1c4b116053b737/html5/thumbnails/1.jpg)
Medical Device
Regulations: Clinical
Impact
European Society of Cardiology
Brussels21 March 2018
Tom Melvin
Medical Officer, HPRA
Co-Chair Clinical Investigation and Evaluation Working Group
![Page 2: Medical Device Regulations: Clinical Impact...Medical Devices 19/03/2018 4 Iterative development vs. disruptive development 19/03/2018 5 Clinical Evaluation Post-Market data Clinical](https://reader030.fdocuments.net/reader030/viewer/2022040611/5ed4b83b0b1c4b116053b737/html5/thumbnails/2.jpg)
Agenda
2
IntroductionMedical Device
Regulation
In Vitro
Diagnostic
Regulation
Implementation
![Page 3: Medical Device Regulations: Clinical Impact...Medical Devices 19/03/2018 4 Iterative development vs. disruptive development 19/03/2018 5 Clinical Evaluation Post-Market data Clinical](https://reader030.fdocuments.net/reader030/viewer/2022040611/5ed4b83b0b1c4b116053b737/html5/thumbnails/3.jpg)
Introduction
![Page 4: Medical Device Regulations: Clinical Impact...Medical Devices 19/03/2018 4 Iterative development vs. disruptive development 19/03/2018 5 Clinical Evaluation Post-Market data Clinical](https://reader030.fdocuments.net/reader030/viewer/2022040611/5ed4b83b0b1c4b116053b737/html5/thumbnails/4.jpg)
Medical Devices
19/03/2018 4
![Page 5: Medical Device Regulations: Clinical Impact...Medical Devices 19/03/2018 4 Iterative development vs. disruptive development 19/03/2018 5 Clinical Evaluation Post-Market data Clinical](https://reader030.fdocuments.net/reader030/viewer/2022040611/5ed4b83b0b1c4b116053b737/html5/thumbnails/5.jpg)
Iterative development vs. disruptive
development
19/03/2018 5
![Page 6: Medical Device Regulations: Clinical Impact...Medical Devices 19/03/2018 4 Iterative development vs. disruptive development 19/03/2018 5 Clinical Evaluation Post-Market data Clinical](https://reader030.fdocuments.net/reader030/viewer/2022040611/5ed4b83b0b1c4b116053b737/html5/thumbnails/6.jpg)
Clinical
Evaluation
Post-Market
data
Clinical
investigation
Clinical data
![Page 7: Medical Device Regulations: Clinical Impact...Medical Devices 19/03/2018 4 Iterative development vs. disruptive development 19/03/2018 5 Clinical Evaluation Post-Market data Clinical](https://reader030.fdocuments.net/reader030/viewer/2022040611/5ed4b83b0b1c4b116053b737/html5/thumbnails/7.jpg)
Changes with the MDR
• Size of
Regulation
• 23 – 123
Articles
• 12 – 16
Annexes
• Legal Basis
• Directive vs.
Regulation
• MEDDEV /
ISO aspects
incorporated
• Scope
• AIMD
• Annex XVI
Slide
8
![Page 8: Medical Device Regulations: Clinical Impact...Medical Devices 19/03/2018 4 Iterative development vs. disruptive development 19/03/2018 5 Clinical Evaluation Post-Market data Clinical](https://reader030.fdocuments.net/reader030/viewer/2022040611/5ed4b83b0b1c4b116053b737/html5/thumbnails/8.jpg)
Medical Device Regulation
![Page 9: Medical Device Regulations: Clinical Impact...Medical Devices 19/03/2018 4 Iterative development vs. disruptive development 19/03/2018 5 Clinical Evaluation Post-Market data Clinical](https://reader030.fdocuments.net/reader030/viewer/2022040611/5ed4b83b0b1c4b116053b737/html5/thumbnails/9.jpg)
MDR – Clinical changes
Clinical evidence
for high risk
devicies
The ‘scrutiny’
procedure
Common
specifications
Summary of
safety and clinical
performance
19/03/2018 10
![Page 10: Medical Device Regulations: Clinical Impact...Medical Devices 19/03/2018 4 Iterative development vs. disruptive development 19/03/2018 5 Clinical Evaluation Post-Market data Clinical](https://reader030.fdocuments.net/reader030/viewer/2022040611/5ed4b83b0b1c4b116053b737/html5/thumbnails/10.jpg)
Clinical Evaluation Consultation – ‘Scrutiny’
• Novelty
• Risk-benefit
• Incident Reports
Criteria
• CEAR
• Risk-benefit
• C/W indication
• PMCF
Expert Panel
Review (CEAR)• Due consideration by
NB
• PMCF/ indication /
SSCP
60 days –
scientific opinion
![Page 11: Medical Device Regulations: Clinical Impact...Medical Devices 19/03/2018 4 Iterative development vs. disruptive development 19/03/2018 5 Clinical Evaluation Post-Market data Clinical](https://reader030.fdocuments.net/reader030/viewer/2022040611/5ed4b83b0b1c4b116053b737/html5/thumbnails/11.jpg)
19/03/2018 12
Competent Authority
Market Surveillance
• Proactive
• Reactive
Scrutiny
• Expert Panel
• High risk devices
Common
Specifications
• Absent / insufficient
standard
• Clinical / technical
guidance
![Page 12: Medical Device Regulations: Clinical Impact...Medical Devices 19/03/2018 4 Iterative development vs. disruptive development 19/03/2018 5 Clinical Evaluation Post-Market data Clinical](https://reader030.fdocuments.net/reader030/viewer/2022040611/5ed4b83b0b1c4b116053b737/html5/thumbnails/12.jpg)
In Vitro Diagnostic Device
Regulation
![Page 13: Medical Device Regulations: Clinical Impact...Medical Devices 19/03/2018 4 Iterative development vs. disruptive development 19/03/2018 5 Clinical Evaluation Post-Market data Clinical](https://reader030.fdocuments.net/reader030/viewer/2022040611/5ed4b83b0b1c4b116053b737/html5/thumbnails/13.jpg)
IVDs
19/03/2018 14
![Page 14: Medical Device Regulations: Clinical Impact...Medical Devices 19/03/2018 4 Iterative development vs. disruptive development 19/03/2018 5 Clinical Evaluation Post-Market data Clinical](https://reader030.fdocuments.net/reader030/viewer/2022040611/5ed4b83b0b1c4b116053b737/html5/thumbnails/14.jpg)
19/03/2018 15
![Page 15: Medical Device Regulations: Clinical Impact...Medical Devices 19/03/2018 4 Iterative development vs. disruptive development 19/03/2018 5 Clinical Evaluation Post-Market data Clinical](https://reader030.fdocuments.net/reader030/viewer/2022040611/5ed4b83b0b1c4b116053b737/html5/thumbnails/15.jpg)
Implementation
![Page 16: Medical Device Regulations: Clinical Impact...Medical Devices 19/03/2018 4 Iterative development vs. disruptive development 19/03/2018 5 Clinical Evaluation Post-Market data Clinical](https://reader030.fdocuments.net/reader030/viewer/2022040611/5ed4b83b0b1c4b116053b737/html5/thumbnails/16.jpg)
CIE: MDR Implementation Work Packages
1. Clinical
Evaluation2. SSCP
3. Template
& Eudamed
4. CIE / IVD
Taskforce
19/03/2018 17
![Page 17: Medical Device Regulations: Clinical Impact...Medical Devices 19/03/2018 4 Iterative development vs. disruptive development 19/03/2018 5 Clinical Evaluation Post-Market data Clinical](https://reader030.fdocuments.net/reader030/viewer/2022040611/5ed4b83b0b1c4b116053b737/html5/thumbnails/17.jpg)
19/03/2018 18
Terms of Reference
![Page 18: Medical Device Regulations: Clinical Impact...Medical Devices 19/03/2018 4 Iterative development vs. disruptive development 19/03/2018 5 Clinical Evaluation Post-Market data Clinical](https://reader030.fdocuments.net/reader030/viewer/2022040611/5ed4b83b0b1c4b116053b737/html5/thumbnails/18.jpg)
Joint Action on Market Surveillance
Member state
communication
Market
surveillance co-
operation
Clinical
resources
Common
specification
prioritisation
19/03/2018 19
![Page 19: Medical Device Regulations: Clinical Impact...Medical Devices 19/03/2018 4 Iterative development vs. disruptive development 19/03/2018 5 Clinical Evaluation Post-Market data Clinical](https://reader030.fdocuments.net/reader030/viewer/2022040611/5ed4b83b0b1c4b116053b737/html5/thumbnails/19.jpg)
Thank You
Health Products Regulatory Authority | An tÚdarás Rialála Táirgí Sláinte
Kevin O’Malley House, Earlsfort Centre, Earlsfort Terrace, Dublin 2,
Ireland
www.hpra.ie